← Leaderboards
Jens Eickhoff
University Of Wisconsin-Madison
$6,015,402
Attributed
$7,260,505
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2023–25$2.5M$1.9M$1.3M$625K$0
'23
'24
'25
Funding mix
By agency
NIH$7,260,505 · 2
By mechanism
U24$4,770,299 · 1
UG1$2,490,206 · 1
Top collaborators
- Suzanne M. Siminski1 shared
Most similar at University Of Wisconsin-Madison
Same institution · by research overlap
- Jane S Paulsen$73,190,829
- Howard Bailey$12,079,664
- Glenn Liu$6,610,633
- Kirk Weeks$1,789,737
- Emery H. Bresnick$23,812,634
Others in their field
Other Rising Stars on “Phase Iii Trial”
- Joan Grand · Mitre Corporation$32,826,287
- Christina Millin · Rho Federal Systems Division, Inc.$32,128,916
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
- Jinsy Andrews · Columbia University Health Sciences$11,474,975
- Eric Anderson · Columbia University Health Sciences$11,474,975
- John Alam · Eip Pharma, Inc.$10,536,018
Research focus
Phase Iii TrialPrevention Clinical TrialMethodologyNational Cancer InstitutePre-ClinicalPreclinical Drug DevelopmentMalignant NeoplasmsClinical DevelopmentMorbidity - Disease RateMortalityBiometryCommunity Clinical Oncology ProgramCarcinogenesisEffective InterventionCancer BurdenEarly Phase TrialData ManagementData ReportingCancer PreventionDivision Of Cancer PreventionDoseClinical TrialsClinical Trials NetworkPreventive